The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

Why are we so ill-prepared for the common cold? It’s not because the common cold has been neglected by scientists or vaccine ...

Bird flu cases are rising earlier than expected as wild birds migrate. That could make for a challenging autumn, but it's too early to say whether egg prices will go up.

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Covid vaccine boosters continue to protect against serious illness and death, especially for people ages 65 and older, ...

Angelica Meyer highlights downstream bioprocessing challenges, emphasizing quality, innovation, and advancing transformative therapies.

Many low-income families who normally get no-cost Covid-19 vaccines for their kids through the Vaccines for Children program ...

Analyses of RNA expression reveal molecules underpinning the cancer-associated process of skeletal-muscle wasting, a ...

In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, ...

The number of “innovation champions” in the pharma industry working on infectious diseases is dropping — and that’s troubling ...

YieldMax ® today announced distributions for the YieldMax ® Weekly Payers and Group B ETFs listed in the table below. Weekly Payers & Group C ETFs scheduled for next week : CHPY GPTY LFGY QDTY RDTY ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...